About the Authors
- Doriana Landi
-
* E-mail: doriana.landi@gmail.com
Affiliations Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy, IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli (Is), Italy
- Maria Albanese
-
Affiliations Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy, IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli (Is), Italy
- Fabio Buttari
-
Affiliations Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy, IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli (Is), Italy
- Fabrizia Monteleone
-
Affiliation Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy
- Laura Boffa
-
Affiliation Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy
- Silvia Rossi
-
Affiliation Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy
- Caterina Motta
-
Affiliation Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy
- Elisa Puma
-
Affiliation Biogen Italy, Medical Department, Milan, Italy
- Diego Centonze
-
Affiliations Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy, IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli (Is), Italy
Competing Interests
DL, MA, FB, LB, and SR have received honoraria for traveling from Almirall, Biogen, Merck Serono, Novartis, and Teva. They are involved as sub-investigators in clinical trials for Biogen, Merck Serono, Novartis, Roche, Sanofi-Aventis, and Teva. FM and CM have received honoraria for traveling from Almirall, Biogen, Merck Serono, Novartis, and Teva. DC is an Advisory Board member of Bayer HealthCare, Biogen, Merck Serono, and Teva. He has received consulting/speaker fees from Almirall, Bayer HealthCare, Biogen, Genzyme, GW Pharmaceuticals, Merck Serono, Novartis, Sanofi-Aventis, and Teva. He is principal investigator in clinical trials for Bayer HealthCare, Biogen, Merck Serono, Novartis, Sanofi-Aventis, and Teva. EP is an employee of Biogen Italy and holds stock/stock options in the company. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: DC. Data curation: DL. Formal analysis: EP. Funding acquisition: DC. Investigation: DL SR CM. Methodology: DC SR. Project administration: LB. Supervision: DC. Writing – original draft: DL MA EP DC. Writing – review & editing: FB FM.